The debate over healthcare price transparency has reached a critical juncture in Congress, with lawmakers in both chambers pushing competing bills that would require hospitals and insurers to disclose real costs. While there is bipartisan consensus on the need for reform, the strength of the proposed legislation varies significantly, and advocates warn that a weaker version could leave patients vulnerable to hidden fees and inflated bills.
Jordan Smith Hart, federal affairs director at the Foundation for Government Accountability, knows firsthand the confusion and fear that opaque pricing can cause. As a 21-year-old college student, she was hospitalized with a blood clot and was told her treatment would cost at least $18,000. The price tag was so alarming that it triggered a panic attack, adding to an already terrifying night.
After the ordeal, Hart requested an itemized bill and discovered that the cash price for her care was less than $900. The hospital had initially planned to charge her insurance company far more, and while the insurer negotiated the rate down, the final bill was still thousands of dollars—far above the cash price.
Hart's experience illustrates a systemic problem: hospitals and providers often set inflated list prices, only for insurers to negotiate discounts behind closed doors. In nearly half of cases, the cash price is lower than the median negotiated rate, meaning patients without insurance—or those who pay out of pocket—are often overcharged.
The current system is the opposite of how other markets function. Consumers expect to know the price of a car, a television, or even a t-shirt before making a purchase. That transparency fosters competition and drives down costs. Healthcare, however, hides prices on the front end and encourages providers and insurers to inflate costs behind the scenes. Hart argues that healthcare billing should operate like every other product or service, with transparent cash prices disclosed upfront so Americans can protect both their health and their wallets.
Lawmakers in both the House and Senate agree on the need for action, but the bills they are debating are not created equal. The Senate's Patients Deserve Price Tags Act is the stronger measure. It requires accurate procedure and treatment pricing to be disclosed in real dollars upfront, covers more medical providers, and prevents federal agencies from issuing waivers. In short, it aims to make price transparency real and enforceable.
The House's Lower Costs, More Transparency Act, however, falls short. It contains loopholes and carveouts that could perpetuate the status quo. For example, when a price isn't a fixed dollar amount, the House bill allows it to remain buried in a formula rather than requiring the formula to be disclosed. It covers fewer providers, offers more exemptions, and allows for waivers that a future administration could use to gut the reform entirely. Hart points to the Biden administration's failure to fully enforce President Trump's 2019 price transparency regulation as evidence that waivers would allow a future president to effectively disregard an entire federal law.
For the sake of Americans, Hart argues, the House and Senate must agree to codify the strongest possible bill. While the Senate language is the best starting point, it could be improved by incorporating elements from the House's CHECK Act, which would expose how health-plan middlemen and their affiliates get paid, guarantee patients a clear explanation of benefits, and require itemized bills. Including these provisions would ensure Americans know exactly what they are paying for and why.
Hart emphasizes that no one should face a financial scare in healthcare, least of all over a manufactured crisis. For her, the panic over the $18,000 price tag felt worse than the blood clot itself. Only the strongest law will protect future patients—whether they are in doctors' offices, getting scans, or receiving life-saving treatments. Americans deserve nothing less than full and total price transparency.
